Cameroon documents
Annual progress reports
All eligible countries are invited to submit proposals for Gavi support.
Annual progress report Cameroon 2011
Annual progress report Cameroon 2010
Annual progress report Cameroon 2009
Annual progress report Cameroon 2008 [Français]
Annual progress report Cameroon 2009 [Français]
Annual progress report Cameroon 2008
Annual progress report Cameroon 2007
Annual progress report Cameroon 2007 [Français]
Annual progress report Cameroon 2004
Annual progress report Cameroon 2006 [Français]
Annual progress report Cameroon 2005 [Français]
Annual progress report Cameroon 2003
Annual progress report Cameroon 2014
Annual progress report Cameroon 2002
Annual progress report Cameroon 2014 [Français]
Annual progress report Cameroon 2002 [Français]
Annual progress report Cameroon 2013
Annual progress report Cameroon 2013 [Français]
Annual progress report Cameroon 2001 [Français]
Annual progress report Cameroon 2012
Approved proposals
All eligible countries are invited to submit proposals for Gavi support.
Proposal for NVS - MR follow-up support 2019 - Cameroon
Proposal for NVS - MR follow-up support 2019 - Cameroon [Français]
Proposal for NVS-HPV(2019-2020): Cameroon
Proposal for NVS - pneumo support 2018: Cameroon
Proposal for NVS - pneumo support 2018: Cameroon [Français]
Proposal for NVS - MR support: Cameroon 2017 [Français]
Proposal for NVS - MR support: Cameroon 2017
Proposal for CCEOP support - Cameroon
Proposal for CCEOP support - Cameroon [Français]
Proposal for HSS support 2016: Cameroon
Proposal for HSS support 2016: Cameroon [Français]
Proposal for NVS - Measles-Rubella support: Cameroon
Proposal for NVS - Measles-Rubella support: Cameroon [Français]
Proposal for NVS - MR: Cameroon
Proposal for NVS - MR: Cameroon [Français]
Proposal for NVS - IPV support: Cameroon
Proposal for NVS - IPV support: Cameroon [Français]
Proposal for HPV Demo: Cameroon
Proposal for HPV Demo: Cameroon [Français]
Proposal for NVS - Rota support: Cameroon
Proposal for NVS - Rota support: Cameroon [Français]
Proposal for NVS- MenA campaign- 2011: Cameroun
Proposal for NVS - Pneumo support: Cameroon
Proposal for NVS - Pneumo support: Cameroon [Français]
Proposal for NVS - Hib support: Cameroon
Proposal for HSS support: Cameroon
Proposal for HSS support: Cameroon [Français]
Proposal for ISS support: Cameroon
Proposal for ISS support: Cameroon [Français]
Proposal for NVS - Hep B support: Cameroon
Proposal for NVS - Hep B support: Cameroon [Français]
Proposal for INS support: Cameroon
Proposal for INS support: Cameroon [Français]
Proposal for ISS support: Cameroon (2001)
Proposal for ISS support: Cameroon (2001) [Français]
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
cMYPs Cameroon 2007-2011
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter Devices Cameroon 2017 [French]
Lettre de decision RSS Cameroun 2013
Decision Letter NVS Cameroon 2017 (2) [French]
Lettre de decision SVN Cameroun 2013
Decision Letter NVS Cameroon 2017 (3) [French]
Partnership Framework Agreement Cameroon
Decision Letter NVS Cameroon 2017 (4) [French]
Lettre de décision SVN Cameroun 2012
Decision Letter NVS Cameroon 2017 (5) [French]
Decision Letter NVS Cameroon 2017 (6) [French]
Decision Letter CCEOP Cameroon 2017 [French]
Lettre de décision SVN Cameroun 2016
Lettre de décision SVN et Matériel Cameroun 2016
Lettre de décision SVN Cameroun 2015 (3)
Lettre de décision SVN Cameroun 2015 (2)
Lettre de décision SVN Cameroun 2015
Letter de Decision Cameroun Sécurité des Injections 2019
Lettre de décision SVN Cameroun 2014(3)
Lettre de Decision Cameroun Rougeole Rubeole 2019
Lettre de décision FCA Cameroun 2014
Lettre de Decision Cameroun VPH 2019
Decision Letter VPH Cameroun 2018 French
Lettre de décision SVN Cameroun 2014(2)
Decision Letter NVS Cameroon 2017 [French]
Lettre de décision SVN Cameroun 2014
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Cameroon 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.
Joint Appraisal Cameroon 2019
Rapport de l'évaluation conjointe Cameroun 2014
Joint Appraisal Cameroon 2018
Joint Appraisal Cameroon 2018 [French]
Joint Appraisal Cameroon 2017 [French]
Rapport de l'évaluation conjointe Cameroun 2016
Rapport de l’évaluation conjointe Cameroun 2015